{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:09:23Z","timestamp":1770156563576,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00108-025-02030-z","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T15:34:12Z","timestamp":1765899252000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dauer der Antibiotikatherapie\u00a0\u2013 wie kurz ist kurz genug?","Duration of antibiotic therapy: how short is short enough?"],"prefix":"10.1007","volume":"67","author":[{"given":"Florian","family":"Hitzenbichler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2030_CR1","doi-asserted-by":"crossref","unstructured":"Trautner BNC\u2011P, Gupta K, Hirsch E, Horstman M (2025) Clinical Practice Guideline by IDSA: 2025 Guideline on management and treatment of complicated urinary tract infections: executive summary. https:\/\/www.idsociety.org\/globalassets\/idsa\/practice-guidelines\/cuti\/executive-summary.pdf","DOI":"10.1093\/cid\/ciaf463"},{"key":"2030_CR2","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour\u00a0LM, Wilson\u00a0WR, Bayer\u00a0AS et\u00a0al (2015) Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A\u00a0Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 132:1435\u20131486","journal-title":"Circulation"},{"key":"2030_CR3","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour\u00a0LM, Wilson\u00a0WR, Bayer\u00a0AS et\u00a0al (2015) Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications. Circulation 132:1435\u20131486","journal-title":"Circulation"},{"key":"2030_CR4","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa2020198","volume":"384","author":"L Bernard","year":"2021","unstructured":"Bernard\u00a0L, Arvieux\u00a0C, Brunschweiler\u00a0B et\u00a0al (2021) Antibiotic Therapy for 6\u00a0or 12\u00a0Weeks for Prosthetic Joint Infection. N\u00a0Engl J Med 384:1991\u20132001","journal-title":"N Engl J Med"},{"key":"2030_CR5","volume-title":"Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2018. PEG AWMF-Registernumme 082-006","author":"K-F Bodmann","year":"2019","unstructured":"Bodmann\u00a0K\u2011F (2019) Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2018. PEG AWMF-Registernumme 082-006"},{"key":"2030_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma\u00a0L, Luyt\u00a0CE, Tubach\u00a0F et\u00a0al (2010) Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a\u00a0multicentre randomised controlled trial. Lancet 375:463\u2013474","journal-title":"Lancet"},{"key":"2030_CR7","doi-asserted-by":"publisher","first-page":"101880","DOI":"10.1016\/j.eclinm.2023.101880","volume":"58","author":"MA Daghmouri","year":"2023","unstructured":"Daghmouri\u00a0MA, Dudoignon\u00a0E, Chaouch\u00a0MA et\u00a0al (2023) Comparison of a\u00a0short versus long-course antibiotic therapy for ventilator-associated pneumonia: a\u00a0systematic review and meta-analysis of randomized controlled trials. EClinicalMedicine 58:101880","journal-title":"EClinicalMedicine"},{"key":"2030_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","volume":"392","author":"N Daneman","year":"2025","unstructured":"Daneman\u00a0N, Rishu\u00a0A, Pinto\u00a0R et\u00a0al (2025) Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections. N\u00a0Engl J Med 392:1065\u20131078","journal-title":"N Engl J Med"},{"key":"2030_CR9","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","volume":"44","author":"V Delgado","year":"2023","unstructured":"Delgado\u00a0V, Ajmone Marsan\u00a0N, De Waha\u00a0S et\u00a0al (2023) 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). Eur Heart\u00a0J 44:3948\u20134042","journal-title":"Eur Heart J"},{"key":"2030_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0140-6736(21)00313-5","volume":"397","author":"A Dinh","year":"2021","unstructured":"Dinh\u00a0A, Ropers\u00a0J, Duran\u00a0C et\u00a0al (2021) Discontinuing \u03b2\u2011lactam treatment after 3\u00a0days for patients with community-acquired pneumonia in non-critical care wards (PTC): a\u00a0double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet 397:1195\u20131203","journal-title":"Lancet"},{"key":"2030_CR11","volume-title":"EAU Guidelines on Urological Infections","author":"GJK Bonkat","year":"2025","unstructured":"Bonkat\u00a0GJK, Cai\u00a0T, Se\u00a0G, K\u00f6ves\u00a0B (2025) EAU Guidelines on Urological Infections"},{"key":"2030_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00108-019-0616-5","volume":"60","author":"F Hitzenbichler","year":"2019","unstructured":"Hitzenbichler\u00a0F, Mohr\u00a0A, Salzberger\u00a0B (2019) Pneumocystis-jirovecii-Pneumonie \u2013 eine opportunistische Infektion im Wandel. Internist 60:669\u2013677","journal-title":"Internist"},{"key":"2030_CR13","volume-title":"Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. AWMF Register Nummer 020-013","author":"JSE Rademacher","year":"2024","unstructured":"Rademacher\u00a0JSE, Grabein\u00a0B, Nachtigall\u00a0I, Pletz\u00a0M, Abele-Horn\u00a0M, Deja\u00a0M, Ga\u00dfner\u00a0M, Gatermann\u00a0S, Geffers\u00a0C, Gerlach\u00a0H, Hagel\u00a0S, Heu\u00dfel\u00a0CP, Kluge\u00a0S, Kolditz\u00a0M, Kramme\u00a0E, K\u00fchl\u00a0H, Panning\u00a0M, Rath\u00a0P\u2011M, Rohde\u00a0G, Schaaf\u00a0B, Salzer\u00a0H, Schreiter\u00a0D, Schweisfurth\u00a0H, Unverzagt\u00a0S, Weigand\u00a0MA, Welte\u00a0T (2024) Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. AWMF Register Nummer 020-013"},{"key":"2030_CR14","doi-asserted-by":"publisher","first-page":"EVIDoa2300054","DOI":"10.1056\/EVIDoa2300054","volume":"2","author":"A Jindani","year":"2023","unstructured":"Jindani\u00a0A, Atwine\u00a0D, Grint\u00a0D et\u00a0al (2023) Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis. NEJM Evid 2:EVIDoa2300054","journal-title":"NEJM Evid"},{"key":"2030_CR15","volume-title":"S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. AWMF Register Nummer 092\/001","author":"KKW De With KW","year":"2018","unstructured":"De With KW\u00a0KKW, De Kern\u00a0W, De Strau\u00df\u00a0R (2018) S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. AWMF Register Nummer 092\/001"},{"key":"2030_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1473-3099(23)00756-9","volume":"24","author":"AJ Kaasch","year":"2024","unstructured":"Kaasch\u00a0AJ, L\u00f3pez-Cort\u00e9s\u00a0LE, Rodr\u00edguez-Ba\u00f1o\u00a0J et\u00a0al (2024) Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial. Lancet Infect Dis 24:523\u2013534","journal-title":"Lancet Infect Dis"},{"key":"2030_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jgar.2020.08.005","volume":"23","author":"SH Lan","year":"2020","unstructured":"Lan\u00a0SH, Lai\u00a0CC, Chang\u00a0SP et\u00a0al (2020) Five-day antibiotic treatment for community-acquired bacterial pneumonia: A\u00a0systematic review and meta-analysis of randomized controlled trials. J\u00a0Glob Antimicrob Resist 23:94\u201399","journal-title":"J Glob Antimicrob Resist"},{"key":"2030_CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/a-1853-4777","volume":"148","author":"C Meyer-Schwickerath","year":"2023","unstructured":"Meyer-Schwickerath\u00a0C, Jochimsen\u00a0D, Jung\u00a0N (2023) Update bone infections. Dtsch Med Wochenschr 148:313\u2013317","journal-title":"Dtsch Med Wochenschr"},{"key":"2030_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cmi.2021.09.001","volume":"28","author":"J Molina","year":"2022","unstructured":"Molina\u00a0J, Montero-Mateos\u00a0E, Praena-Segovia\u00a0J et\u00a0al (2022) Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a\u00a0randomized, controlled trial. Clin Microbiol Infect 28:550\u2013557","journal-title":"Clin Microbiol Infect"},{"key":"2030_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00134-018-5088-x","volume":"44","author":"P Montravers","year":"2018","unstructured":"Montravers\u00a0P, Tubach\u00a0F, Lescot\u00a0T et\u00a0al (2018) Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med 44:300\u2013310","journal-title":"Intensive Care Med"},{"key":"2030_CR21","doi-asserted-by":"crossref","unstructured":"Reinhold I, Picardi S, Liss B et\u00a0al (2025) Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults. Lancet Infect Dis","DOI":"10.1016\/S1473-3099(25)00409-8"},{"key":"2030_CR22","volume-title":"Leitlinie Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie \u2013 Update 2021. AWMF Register Nummer 020-020","author":"S Ewig","year":"2021","unstructured":"Ewig\u00a0S (2021) Leitlinie Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie \u2013 Update 2021. AWMF Register Nummer 020-020"},{"key":"2030_CR23","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","volume":"372","author":"RG Sawyer","year":"2015","unstructured":"Sawyer\u00a0RG, Claridge\u00a0JA, Nathens\u00a0AB et\u00a0al (2015) Trial of short-course antimicrobial therapy for intraabdominal infection. N\u00a0Engl J Med 372:1996\u20132005","journal-title":"N Engl J Med"},{"key":"2030_CR24","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamainternmed.2016.3646","volume":"176","author":"B Spellberg","year":"2016","unstructured":"Spellberg\u00a0B (2016) The New Antibiotic Mantra\u2014\u201cShorter Is Bette. JAMA Intern Med 176:1254\u20131255","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2030_CR25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann\u00a0AJ, Aguado\u00a0JM, Arikan-Akdagli\u00a0S et\u00a0al (2018) Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 24(1):e1\u2013e38","journal-title":"Clin Microbiol Infect"},{"key":"2030_CR26","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2020.6348","volume":"323","author":"E Von Dach","year":"2020","unstructured":"Von Dach\u00a0E, Albrich\u00a0WC, Brunel\u00a0AS et\u00a0al (2020) Effect of C\u2011Reactive Protein-Guided Antibiotic Treatment Duration, 7\u2011Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A\u00a0Randomized Clinical Trial. JAMA 323:2160\u20132169","journal-title":"JAMA"},{"key":"2030_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","volume":"69","author":"D Yahav","year":"2019","unstructured":"Yahav\u00a0D, Franceschini\u00a0E, Koppel\u00a0F et\u00a0al (2019) Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A\u00a0Noninferiority Randomized Controlled Trial. Clin Infect Dis 69:1091\u20131098","journal-title":"Clin Infect Dis"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-02030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-02030-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-02030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:01:20Z","timestamp":1769522480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-02030-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2030"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-02030-z","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Hitzenbichler: Vortragshonorare von der Akademie f\u00fcr Infektionsmedizin, Pfizer Pharma GmbH und MSD Sharp & Dohme an, sowie Kongressgeb\u00fchren und Reisekosten von Gilead Sciences und Tillotts Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}